Completed OBSERVATIONAL NCT02858375

Long-Term Assessment of Quality of Life and Effectiveness of Onabotulinumtoxina Injections in Provoked Vestibulodynia (QUALVESTO)

Sponsor: Centre Hospitalier Universitaire de Besancon

Updated 6 times since 2017 Last updated: Aug 3, 2016 Started: Mar 31, 2013 Primary completion: Apr 30, 2013 Completion: Apr 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02858375, this observational or N/A phase trial focuses on Vestibulodynia and remains completed. Sponsored by Centre Hospitalier Universitaire de Besancon, it has been updated 6 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Mar 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Universitaire de Besancon

Data source: Centre Hospitalier Universitaire de Besancon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Besançon, France